Clarivate (NYSE:CLVT) Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPS

Clarivate (NYSE:CLVT) announced its quarterly earnings results on Wednesday. The company reported $0.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.18 by $0.03, FiscalAI reports. The firm had revenue of $481.60 million for the quarter, compared to the consensus estimate of $566.77 million. Clarivate had a negative net margin of 13.84% and a positive return on equity of 9.15%. The firm’s quarterly revenue was down 22.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.18 earnings per share.

Clarivate Stock Performance

Shares of CLVT traded up $0.07 during mid-day trading on Wednesday, reaching $2.15. 5,042,023 shares of the company’s stock were exchanged, compared to its average volume of 6,009,917. The business’s fifty day simple moving average is $1.81 and its 200-day simple moving average is $2.22. The stock has a market capitalization of $1.38 billion, a PE ratio of -4.12 and a beta of 1.38. Clarivate has a 52-week low of $1.42 and a 52-week high of $3.87. The company has a debt-to-equity ratio of 0.93, a current ratio of 0.85 and a quick ratio of 0.85.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on CLVT. Barclays cut their price objective on shares of Clarivate from $2.50 to $2.00 and set an “underweight” rating for the company in a research report on Thursday, July 30th. Wall Street Zen lowered shares of Clarivate from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. Citigroup decreased their price objective on Clarivate from $2.80 to $2.50 and set a “neutral” rating on the stock in a report on Thursday, July 30th. The Goldman Sachs Group reduced their target price on Clarivate from $2.90 to $2.60 and set a “neutral” rating on the stock in a research report on Thursday, July 30th. Finally, William Blair downgraded Clarivate to a “market perform” rating in a research report on Thursday, October 15th. One research analyst has rated the stock with a Buy rating, four have given a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Reduce” and an average target price of $2.77.

Key Stories Impacting Clarivate

Here are the key news stories impacting Clarivate this week:

• Positive Sentiment: Clarivate said recurring organic revenue growth improved and its Intellectual Property segment returned to positive annual contract value growth. It also reported adjusted EPS of $0.21, ahead of estimates, and expects 2027 free cash flow to grow 10%–15% following the Life Sciences & Healthcare divestiture. Clarivate Q3 results 2027 free cash flow outlook
• Positive Sentiment: A strategic alliance with Microsoft will bring Clarivate’s trademark data into Microsoft Copilot through IPOne, offering a potential channel to expand the reach of its data and AI-enabled services. Microsoft alliance announcement
• Neutral Sentiment: Clarivate launched cash tender offers for up to $500 million of its 2028 and 2029 notes. The move could help manage debt, but it also uses cash; the ultimate impact depends on how much debt is repurchased and the transaction terms. Debt tender offer announcement
• Negative Sentiment: Q3 revenue was $481.6 million, well below the roughly $567 million consensus estimate, and declined 22.7% year over year. The revenue miss outweighed the EPS beat and was reported to have driven a sharp share decline, keeping questions about growth and the effects of the portfolio changes in focus. Q3 revenue miss and share reaction

Insider Buying and Selling at Clarivate

In other news, Director Kenneth Cornick acquired 250,000 shares of the stock in a transaction that occurred on Friday, August 7th. The shares were purchased at an average cost of $1.85 per share, for a total transaction of $462,500.00. Following the transaction, the director directly owned 2,000,000 shares in the company, valued at approximately $3,700,000. This represents a 14.29% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 22.88% of the company’s stock.

About Clarivate

Clarivate Plc (NYSE:CLVT) provides analytics, data, and workflow solutions to organizations in academia, government, research, life sciences, and intellectual property. Its offerings are designed to help customers evaluate research, manage information, accelerate innovation, and support strategic decision-making.

The company’s products include Web of Science research databases and citation analytics, InCites research evaluation tools, Derwent innovation and patent intelligence services, and Cortellis life sciences and drug-development information.